MAPK3 and breast cancer: In light of this, the immunoreactivity of Total- and Phosphorylated- AKT and ERK1/2 within the cytoplasm and nucleus of cells from normal breast, primary and metastatic cancers were investigated to determine their role in the downstream signalling events during the development and progression of breast cancer.